ctrl K

AI Score

Unlock

Century Therapeutics Inc. (IPSC)

AI Score

Unlock

0.64

-0.04 (-6.27%)

At close: Mar 03, 2025, 11:33 AM

Century Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	2.23M	5.2M	n/a	n/a	n/a
Cost of Revenue	13.04M	10.07M	4.58M	1.75M	249K
Gross Profit	-10.81M	-4.87M	-4.58M	-1.75M	-249K
Operating Income	-146.55M	-133.83M	-94.88M	-53.9M	-245.98M
Interest Income	12.68M	2.99M	898K	704K	1.21M
Pretax Income	-134.79M	-130.84M	-95.78M	-53.58M	-244.77M
Net Income	-136.67M	-130.93M	-95.82M	-54.66M	-245.98M
Selling & General & Admin	34.71M	31.86M	19.23M	9.49M	5.77M
Research & Development	92.71M	107.17M	75.65M	39.68M	14.27M
Other Expenses	21.36M	4.42M	377K	704K	1.21M
Operating Expenses	148.78M	139.03M	94.88M	49.18M	20.03M
Interest Expense	540K	1.1M	1.27M	381K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	148.78M	139.03M	94.88M	49.18M	20.03M
Income Tax	1.88M	91K	43K	1.08M	1.21M
Shares Outstanding (Basic)	59.31M	57.76M	55.01M	54.82M	54.82M
Shares Outstanding (Diluted)	59.31M	57.76M	55.01M	54.82M	54.82M
EPS (Basic)	-2.3	-2.27	-1.74	-1	-4.49
EPS (Diluted)	-2.3	-2.27	-1.74	-1	-4.49
EBITDA	-121.21M	-119.34M	-89.92M	-51.44M	-19.78M
Depreciation & Amortization	13.04M	10.07M	4.58M	1.75M	249K